Povidone Iodine vaginal cleansing trial

Not Applicable

• Conditions: Pregnancy and Childbirth; Postoperative infectious morbidity

• Registration Number: PACTR202112553386036
• Lead Sponsor: John Okafor Egede

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-11-23
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 480

Inclusion Criteria

All consented parturient
Undergoing elective or emergency caesarean section
After the age of fetal viability (= 28weeks gestational age).

Exclusion Criteria

Refusal of consent.
Women with known allergy to topical Povidone-iodine or on treatment with iodine or radiotherapy
Placenta praevia.
Cord prolapse
Face presentation with ruptured membranes to avoid contact of fetal face with iodine.
Ruptured uterus
Thyroid disorders

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome measure was post caesarean endometritis

Secondary Outcome Measures

Name	Time	Method
Post-caesarean wound infection<br>Postoperative fever<br>Duration of hospitalisation due to infectious morbidity.<br>Adverse reaction to povidone iodine<br>